Co-Authors
This is a "connection" page, showing publications co-authored by Sophie Susen and Alain Duhamel.
Connection Strength
0.684
-
Coagulation biomarkers are independent predictors of increased oxygen requirements in COVID-19. J Thromb Haemost. 2020 11; 18(11):2942-2953.
Score: 0.226
-
Therapeutic and pharmaco-biological, dose-ranging multicentre trial to determine the optimal dose of TRAnexamic acid to reduce blood loss in haemorrhagic CESarean delivery (TRACES): study protocol for a randomised, double-blind, placebo-controlled trial. Trials. 2018 Mar 01; 19(1):148.
Score: 0.189
-
Vascular Endothelial Damage in the Pathogenesis of Organ Injury in Severe COVID-19. Arterioscler Thromb Vasc Biol. 2021 05 05; 41(5):1760-1773.
Score: 0.058
-
Severe SARS-CoV-2 patients develop a higher specific T-cell response. Clin Transl Immunology. 2020; 9(12):e1217.
Score: 0.058
-
Endotheliopathy Is Induced by Plasma From Critically Ill Patients and Associated With Organ Failure in Severe COVID-19. Circulation. 2020 11 10; 142(19):1881-1884.
Score: 0.057
-
Primary Hemostatic Disorders and Late Major Bleeding After Transcatheter Aortic Valve Replacement. J Am Coll Cardiol. 2018 10 30; 72(18):2139-2148.
Score: 0.050
-
TRAnexamic acid in hemorrhagic CESarean section (TRACES) randomized placebo controlled dose-ranging pharmacobiological ancillary trial: study protocol for a randomized controlled trial. Trials. 2018 Mar 01; 19(1):149.
Score: 0.047